Case Note & Summary
The Supreme Court addressed an appeal against the Madhya Pradesh High Court's order rejecting the appellants' application to quash a complaint under the Drugs and Cosmetics Act, 1940. The dispute arose after a sample of Betnesol tablets, manufactured by the appellants, was found to be of sub-standard quality by a government analyst. Following the issuance of a show cause notice, the appellants failed to express their intention to challenge the analyst's report within the stipulated 28-day period. The appellants contended that the complaint was filed after an unreasonable delay, given that the medicine had expired. The respondent argued that the appellants had not complied with the necessary legal provisions to contest the report. The court emphasized that the report of the analyst is conclusive and that the appellants' failure to notify their intention to adduce evidence within the limitation period barred them from challenging the complaint. The court distinguished the case from precedents cited by the appellants, asserting that the facts were not comparable. Ultimately, the court found no merit in the appeal and upheld the High Court's decision, dismissing the appeal.
Headnote
A) Criminal Law - Quashing of Complaint - Delay in Filing - The High Court's rejection of the application for quashing the complaint was upheld as the appellants did not express intention to adduce evidence in contravention of the analyst's report within the statutory limitation period of 28 days as prescribed under Section 25(3) of the Drugs and Cosmetics Act, 1940. The court noted that the delay in filing the complaint was immaterial due to the appellants' failure to comply with statutory requirements (Paras 8-12).
Issue of Consideration
Whether the complaint against the appellants under the Drugs and Cosmetics Act, 1940 was maintainable despite the delay in filing it and the appellants' failure to express their intention to adduce evidence in contravention of the analyst's report.
Final Decision
The Supreme Court dismissed the appeal, affirming the High Court's decision to reject the application for quashing the complaint. The court held that the appellants did not express their intention to adduce evidence in contravention of the analyst's report within the statutory limitation period, rendering the complaint maintainable despite any delay in filing.
Law Points
- Quashing of complaint
- Limitation period
- Standard quality of drugs
- Rights of manufacturers
- Chemical analysis
- Compliance with statutory provisions
